Dechert advised Quest Diagnostics on the transaction. Quest Diagnostics, a leading provider of diagnostic information services, announced a definitive agreement to acquire select assets of the...
You must be a Standard 1 Year member to access this content.
Dechert LLP advised Crown Holdings on the transaction. Crown Holdings, Inc. (Crown) executed an offering of €600 million aggregate principal amount of 4.500% senior unsecured notes...
You must be a Standard 1 Year member to access this content.
Dechert advised Quest Diagnostics on the deal. Quest Diagnostics, a leading provider of diagnostic information services, signed a definitive agreement for Quest to acquire select assets...
You must be a Standard 1 Year member to access this content.
Dechert advised Quest Diagnostics o the deal. Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and Allina Health, a leading, non-profit health care...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Boyd Watterson, Dechert advised Amber and Hunt, and Milbank advised Amber’s minority shareholders on the deal. Boyd Watterson Asset Management, LLC (“Boyd Watterson”)...
You must be a Standard 1 Year member to access this content.
Dechert has been engaged as legal advisor to the Special Committee of the Board of Directors of 23andMe Holding Co. 23andMe Holding Co. (Nasdaq: ME), a...
You must be a Standard 1 Year member to access this content.
Dechert advised Quest Diagnostics on the deal. Quest Diagnostics, the world’s leading provider of diagnostic information service, announced its acquisition of the assets of Lenco Diagnostic Laboratories, Inc.,...
You must be a Standard 1 Year member to access this content.
Dechert LLP advised Quest Diagnostics on the deal. Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced it has acquired select assets...
You must be a Standard 1 Year member to access this content.
Dechert advised Emmes on the transaction. Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Balch & Bingham are serving as legal advisors to Vistra, while Dechert is serving as corporate legal counsel, and Morgan, Lewis &...
You must be a Standard 1 Year member to access this content.
Dechert LLP advised Quest Diagnostics in the deal. Quest Diagnostics announced a strategic agreement designed to broaden access to quality, innovative laboratory services for the providers...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
